News
Bausch & Lomb Reports Weak Start to 2025 as enVista Recall, Tariffs, and Drug Pricing Cause Concerns
Ophthalmic pharmaceuticals drive ... There are already generic alternatives for certain forms of Lotemax, and besides the two mentioned drugs, there are a number of other drugs that are set ...
President Donald Trump’s promise to impose tariffs on pharmaceutical imports is raising red flags among generic drugmakers and industry experts, who warn that such a move could lead to increased ...
Ophthalmic pharmaceuticals drive ... There are already generic alternatives for certain forms of Lotemax, and besides the two mentioned drugs, there are a number of other drugs that are set ...
Glenmark Pharmaceuticals Inc., USA announced today the launch of Latanoprost Ophthalmic Solution, 0.005 per cent, a generic version of Upjohn’s Xalatan. This marks the company’s fourth ...
The first medication is loteprednol etabonate ophthalmic gel, 0.38%, which is a generic of Bausch & Lomb’s Lotemax. Lupin is the exclusive first-to-file for this product and may be eligible to ...
Loteprednol Etabonate Ophthalmic Gel, 0.38% (RLD Lotemax SM) had an estimated annual sale of USD ... company had received approval from the U.S. FDA for its Abbreviated New Drug Application for ...
According to the company’s statement, the approval has been granted to market a generic equivalent of Lotemax® SM Ophthalmic Gel of Bausch & Lomb Inc. Lupin is the exclusive first-to-file for ...
for its Abbreviated New Drug Application for loteprednol etabonate ophthalmic gel, 0.38%, to market a generic equivalent of Lotemax SM ophthalmic gel of Bausch & Lomb Inc. Lupin is the exclusive first ...
In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.
Miebo eye drops represent a breakthrough for treating dry eye disease ... However, being a newer brand name drug with exclusive patented technology, Miebo commands a significant price premium compared ...
We limited our analysis to reports in which the drug was classified as the primary ... through screening via four signal detection methods, the number of ophthalmic-related PTs identified were: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results